| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 68.97× | 68.97× | 75.19× | 69.55× | 61.34× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.62× | 1.65× | 1.71× | 2.30× | 2.94× | ||
| 1.14× | 1.14× | 0.97× | 0.89× | 0.92× | ||
| 0.98× | 0.98× | 1.32× | 1.94× | 2.15× | ||
| 0.75× | 0.75× | 0.73× | 0.86× | 1.09× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 61.34 | 69.55 | 75.19 | 68.97 | 68.97 | |
| Working Capital Turnover | 2.94 | 2.30 | 1.71 | 1.65 | 1.62 | |
| Asset Turnover | 0.92 | 0.89 | 0.97 | 1.14 | 1.14 | |
| Cash Conversion (CFO/Net Income) | 2.15 | 1.94 | 1.32 | 0.98 | 0.98 | |
| CFO/EBITDA | 1.09 | 0.86 | 0.73 | 0.75 | 0.75 |